{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:55:13Z","timestamp":1790729713486,"version":"4.1.0"},"reference-count":20,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"13","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurosurg Case Lessons"],"published-print":{"date-parts":[[2026,9,28]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>\n                      Primary CNS sarcoma,\n                      <jats:italic>DICER1<\/jats:italic>\n                      -mutant is almost exclusively found in the supratentorial compartment. Isolated spinal lesions are exceedingly rare.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBSERVATIONS<\/jats:title>\n                    <jats:p>\n                      The authors present a case of thoracic intradural extramedullary primary CNS sarcoma,\n                      <jats:italic>DICER1<\/jats:italic>\n                      -mutant. An adult male with a remote history of a left cerebellar lesion resection with unknown pathology presented with sensation changes extending caudally from the torso. He subsequently underwent laminectomy and tumor resection of the lesion. The patient experienced recurrence at 1.5 months requiring re-resection for palliative decompression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>LESSONS<\/jats:title>\n                    <jats:p>Molecular characterization is essential for accurate diagnosis of this rare entity given its substantial overlap with histological mimics. Following resection and tissue identification of the tumor, patients should be monitored closely for local recurrence. While no standardized treatment exists, adjuvant chemoradiation therapy may improve time to progression and overall survival in an otherwise aggressive disease.<\/jats:p>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/thejns.org\/doi\/10.3171\/CASE26660\">https:\/\/thejns.org\/doi\/10.3171\/CASE26660<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3171\/case26660","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:03:36Z","timestamp":1790121816000},"source":"Crossref","is-referenced-by-count":0,"title":["Primary CNS sarcoma, DICER1-mutant with rhabdomyoblastic differentiation arising within the thoracic spine: illustrative case"],"prefix":"10.3171","volume":"12","author":[{"given":"John T.","family":"Tsiang","sequence":"first","affiliation":[{"name":"Department of Neurological Surgery, Rush University Medical Center, Chicago"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9173-7350","authenticated-orcid":true,"given":"Tiffany M.","family":"San","sequence":"additional","affiliation":[{"name":"Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Daniel","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Loyola University Medical Center, Maywood"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5687-6488","authenticated-orcid":true,"given":"Ronak H.","family":"Jani","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Loyola University Medical Center, Maywood"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather L.","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Loyola University Medical Center, Maywood, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Arnold","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Loyola University Medical Center, Maywood"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"issue":"8","key":"bib1","series-title":"Neuro Oncol","first-page":"1231","article-title":"The 2021 WHO Classification of Tumors of the Central Nervous System: a summary","volume":"23","author":"Louis","year":"2021","unstructured":"Louis DNPerry AWesseling PThe 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021;23(8):1231-1251. doi:10.1093\/neuonc\/noab106"},{"issue":"4","key":"bib2","series-title":"Cancer","first-page":"697","article-title":"Primary central nervous system sarcoma with DICER1 mutation\u2014treatment results of a novel molecular entity in pediatric Peruvian patients","volume":"128","author":"Diaz Coronado","year":"2022","unstructured":"Diaz Coronado RYMynarek MKoelsche CPrimary central nervous system sarcoma with DICER1 mutation\u2014treatment results of a novel molecular entity in pediatric Peruvian patients. Cancer. 2022;128(4):697-707. doi:10.1002\/cncr.33977"},{"issue":"4","key":"bib3","series-title":"Neurooncol Pract","first-page":"381","article-title":"DICER1-associated central nervous system sarcoma: a comprehensive clinical and genomic characterization of case series of young adult patients","volume":"10","author":"Cardona","year":"2023","unstructured":"Cardona AFChamorro Ortiz DFRu\u00edz-Pati\u00f1o ADICER1-associated central nervous system sarcoma: a comprehensive clinical and genomic characterization of case series of young adult patients. Neurooncol Pract. 2023;10(4):381-390. doi:10.1093\/nop\/npad014"},{"issue":"12","key":"bib4","series-title":"Mod Pathol","first-page":"2096","article-title":"DICER1-sarcoma: an emerging entity","volume":"34","author":"McCluggage","year":"2021","unstructured":"McCluggage WGFoulkes WD.DICER1-sarcoma: an emerging entity. Mod Pathol. 2021;34(12):2096-2097. doi:10.1038\/s41379-021-00935-2"},{"issue":"1","key":"bib5","series-title":"Acta Neuropathol Commun","first-page":"22","article-title":"Mesenchymal non-meningothelial tumors of the central nervous system: a literature review and diagnostic update of novelties and emerging entities","volume":"11","author":"Tauzi\u00e8de-Espariat","year":"2023","unstructured":"Tauzi\u00e8de-Espariat AHasty LM\u00e9tais AVarlet P.Mesenchymal non-meningothelial tumors of the central nervous system: a literature review and diagnostic update of novelties and emerging entities. Acta Neuropathol Commun. 2023;11(1):22. doi:10.1186\/s40478-023-01522-z"},{"key":"bib6","series-title":"Can J Neurol Sci","article-title":"A primary CNS sarcoma of the spinal cord with DICER1 mutation: expanding the spectrum of DICER1-driven CNS sarcomas","author":"Pasarikovski","year":"2025","unstructured":"Pasarikovski CRDavalan WRossiter JPAlkins R.A primary CNS sarcoma of the spinal cord with DICER1 mutation: expanding the spectrum of DICER1-driven CNS sarcomas. Can J Neurol Sci. Published online December 12, 2025. doi:10.1017\/cjn.2025.10489"},{"issue":"6","key":"bib7","series-title":"Neuropathol Appl Neurobiol","first-page":"e12830","article-title":"Evidence of neural crest cell origin of a DICER1 mutant CNS sarcoma in a child with DICER1 syndrome and NRAS-mutant neurocutaneous melanosis","volume":"48","author":"Schweizer","year":"2022","unstructured":"Schweizer LHartmann WKoch AEvidence of neural crest cell origin of a DICER1 mutant CNS sarcoma in a child with DICER1 syndrome and NRAS-mutant neurocutaneous melanosis. Neuropathol Appl Neurobiol. 2022;48(6):e12830. doi:10.1111\/nan.12830"},{"issue":"suppl 3","key":"bib8","series-title":"Neuro Oncol","first-page":"iii4.","article-title":"AT-13THE EU-RHAB experience: clinical, genetic and survival data define a standard of care and are the basis for clinical trials","volume":"18","author":"Fr\u00fchwald","year":"2016","unstructured":"Fr\u00fchwald MNemes KSchlegel PGAT-13THE EU-RHAB experience: clinical, genetic and survival data define a standard of care and are the basis for clinical trials. Neuro Oncol. 2016;18(suppl 3):iii4. doi:10.1093\/neuonc\/now065.12"},{"issue":"1","key":"bib9","series-title":"Nat Commun","first-page":"498","article-title":"Sarcoma classification by DNA methylation profiling","volume":"12","author":"Koelsche","year":"2021","unstructured":"Koelsche CSchrimpf DStichel DSarcoma classification by DNA methylation profiling. Nat Commun. 2021;12(1):498. doi:10.1038\/s41467-020-20603-4"},{"issue":"3","key":"bib10","series-title":"J Neurosurg Pediatr","first-page":"298","article-title":"Successful treatment of primary intracranial sarcoma with the ICE chemotherapy regimen and focal radiation in children","volume":"17","author":"Lafay-Cousin","year":"2016","unstructured":"Lafay-Cousin LLindzon GTaylor MDSuccessful treatment of primary intracranial sarcoma with the ICE chemotherapy regimen and focal radiation in children. J Neurosurg Pediatr. 2016;17(3):298-302. doi:10.3171\/2015.6.PEDS14709"},{"key":"bib11","series-title":"WHO Classification of Tumours of the Central Nervous System","article-title":"Primary intracranial sarcoma","author":"Solomon","year":"2021","unstructured":"Solomon DPfister Svon Deimling APrimary intracranial sarcoma. In: WHO Classification of Tumours of the Central Nervous System. International Agency for Research on Cancer; 2021. Accessed June 16, 2026. https:\/\/tumourclassification.iarc.who.int\/chapters\/45"},{"issue":"5","key":"bib12","series-title":"Int J Surg Pathol","first-page":"1196","article-title":"Primary intracranial sarcoma, DICER1-mutant, with prominent chondroid differentiation: case report and summary of reported patients in literature","volume":"33","author":"Karia","year":"2025","unstructured":"Karia KEschbacher KL.Primary intracranial sarcoma, DICER1-mutant, with prominent chondroid differentiation: case report and summary of reported patients in literature. Int J Surg Pathol. 2025;33(5):1196-1201. doi:10.1177\/10668969241300502"},{"issue":"1","key":"bib13","series-title":"Mod Pathol","first-page":"164","article-title":"Expanding the spectrum of dicer1-associated sarcomas","volume":"33","author":"Warren","year":"2020","unstructured":"Warren MHiemenz MCSchmidt RExpanding the spectrum of dicer1-associated sarcomas. Mod Pathol. 2020;33(1):164-174. doi:10.1038\/s41379-019-0366-x"},{"issue":"2","key":"bib14","series-title":"Histopathology","first-page":"265","article-title":"Loss of histone H3 trimethylation on lysine 27 and nuclear expression of transducin-like enhancer 1 in primary intracranial sarcoma, DICER1-mutant","volume":"78","author":"Alexandrescu","year":"2021","unstructured":"Alexandrescu SMeredith DMLidov HGLoss of histone H3 trimethylation on lysine 27 and nuclear expression of transducin-like enhancer 1 in primary intracranial sarcoma, DICER1-mutant. Histopathology. 2021;78(2):265-275. doi:10.1111\/his.14217"},{"issue":"2","key":"bib15","series-title":"J Neuropathol Exp Neurol","first-page":"198","article-title":"Primary sporadic intracranial DICER1 mutant sarcoma with SSTR2 positivity in an adult patient mimicking anaplastic meningioma","volume":"85","author":"Welch","year":"2026","unstructured":"Welch RLFluss RSYokoda RTHimes BT.Primary sporadic intracranial DICER1 mutant sarcoma with SSTR2 positivity in an adult patient mimicking anaplastic meningioma. J Neuropathol Exp Neurol. 2026;85(2):198-202. doi:10.1093\/jnen\/nlaf053"},{"issue":"2","key":"bib16","series-title":"Acta Neuropathol","first-page":"181","article-title":"Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience","volume":"136","author":"Capper","year":"2018","unstructured":"Capper DStichel DSahm FPractical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience. Acta Neuropathol. 2018;136(2):181-210. doi:10.1007\/s00401-018-1879-y"},{"issue":"3","key":"bib17","series-title":"N Engl J Med","first-page":"234","article-title":"Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers","volume":"366","author":"Heravi-Moussavi","year":"2012","unstructured":"Heravi-Moussavi AAnglesio MSCheng SWGRecurrent somatic DICER1 mutations in nonepithelial ovarian cancers. N Engl J Med. 2012;366(3):234-242. doi:10.1056\/NEJMoa1102903"},{"issue":"1","key":"bib18","series-title":"Nat Commun","first-page":"3682","article-title":"Cancer-associated mutations in DICER1 RNase IIIa and IIIb domains exert similar effects on miRNA biogenesis","volume":"10","author":"Vedanayagam","year":"2019","unstructured":"Vedanayagam JChatila WKAksoy BACancer-associated mutations in DICER1 RNase IIIa and IIIb domains exert similar effects on miRNA biogenesis. Nat Commun. 2019;10(1):3682. doi:10.1038\/s41467-019-11610-1"},{"issue":"3","key":"bib19","series-title":"J Neurosurg Pediatr","first-page":"308","article-title":"A systematic review of the clinicopathological features and prognostic outcomes of DICER1-mutant malignant brain neoplasms","volume":"30","author":"Vuong","year":"2022","unstructured":"Vuong HGLe MKDunn IF.A systematic review of the clinicopathological features and prognostic outcomes of DICER1-mutant malignant brain neoplasms. J Neurosurg Pediatr. 2022;30(3):308-315. doi:10.3171\/2022.6.PEDS22119"},{"issue":"8","key":"bib20","series-title":"Mod Pathol","first-page":"1558","article-title":"Clinicopathologic and molecular analysis of embryonal rhabdomyosarcoma of the genitourinary tract: evidence for a distinct DICER1-associated subgroup","volume":"34","author":"Kommoss","year":"2021","unstructured":"Kommoss FKFStichel DMora JClinicopathologic and molecular analysis of embryonal rhabdomyosarcoma of the genitourinary tract: evidence for a distinct DICER1-associated subgroup. Mod Pathol. 2021;34(8):1558-1569. doi:10.1038\/s41379-021-00804-y"}],"container-title":["Journal of Neurosurgery: Case Lessons"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-case-lessons\/12\/13\/article-CASE26660.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-case-lessons\/12\/13\/article-CASE26660.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-case-lessons\/12\/13\/article-CASE26660.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:55Z","timestamp":1790726455000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-case-lessons\/12\/13\/article-CASE26660.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":20,"journal-issue":{"issue":"13"},"URL":"https:\/\/doi.org\/10.3171\/case26660","relation":{},"ISSN":["2694-1902"],"issn-type":[{"value":"2694-1902","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]}}}